Finding 1166793 (2024-011)

Material Weakness Repeat Finding
Requirement
B
Questioned Costs
-
Year
2024
Accepted
2025-12-29

AI Summary

  • Core Issue: Direct charges for major improvements to real property are not allowed under UC program funding.
  • Impacted Requirements: Costs related to acquisition, construction, or major capital improvements must be capitalized and depreciated, not directly charged.
  • Recommended Follow-Up: Re-establish internal controls to monitor allowable expenses and ensure proper reconciliation of costs with cash draws.

Finding Text

Finding: Direct charges for major improvements of real property. Criteria: Allowable Costs/ Cost Principles (Non-profit Organization) Per the Compliance Supplement for UC programs, improper direct charging of costs related to the acquisition, construction, or major capital improvements of real property is unallowable. Funding under this program cannot be directly used for any of these purposes as the program does not have statutory authority to do so. Expenses such as direct charges of acquisition costs, mortgage principal and interest payments, and direct charges for alterations to real property which are considered major capital improvements* and required to be capitalized and depreciated under GAAP, are unallowable as direct charges to the UC Program awards. Only depreciation properly calculated (see 45 CFR 75.436), recorded, and supported by the recipient organization in accordance with GAAP may be charged to UC Program awards. Condition and Context, and Cause: During our audit, noted to charges to the UC programs which were unallowable per the above criteria. See discussion above at 2024-006 additional context/cause. Result: Amounts identified as unallowable costs per the compliance guidance have been included in the contract liability as disclosed in Note 12. See the Summary of Unallowable Costs and Questioned Costs tables for detail on page 56. Recommendation: The auditors recommend the Organization re-implement internal controls to track allowable expenditures and reconcile qualifying costs with cash draws.

Corrective Action Plan

Cayuga Centers will confer with its auditors to ensure it has a full list of general ledger (GL) transactions regarding which these findings are asserted. For finding 2024-011, Cayuga Centers will assess whether each transaction does, in fact, represent a capital cost and will assess all such costs against program requirements and other relevant background documentation. For finding 2024-012, Cayuga will review relevant lease terms and program requirements. If, upon full evaluation, Cayuga Centers concurs that such costs were improperly charged, it will address the matter with its primary funding agency as part of broader resolution of any unallowable costs. For steps to resolve the underlying control deficiency asserted or implied in this finding, please see Cayuga Centers’ response to Findings 2024-001 through 006 above.

Categories

Allowable Costs / Cost Principles

Other Findings in this Audit

  • 1166741 2024-003
    Material Weakness Repeat
  • 1166742 2024-004
    Material Weakness Repeat
  • 1166743 2024-005
    Material Weakness Repeat
  • 1166744 2024-006
    Material Weakness Repeat
  • 1166745 2024-007
    Material Weakness Repeat
  • 1166746 2024-008
    Material Weakness Repeat
  • 1166747 2024-009
    Material Weakness Repeat
  • 1166748 2024-010
    Material Weakness Repeat
  • 1166749 2024-011
    Material Weakness Repeat
  • 1166750 2024-012
    Material Weakness Repeat
  • 1166751 2024-013
    Material Weakness Repeat
  • 1166752 2024-003
    Material Weakness Repeat
  • 1166753 2024-004
    Material Weakness Repeat
  • 1166754 2024-005
    Material Weakness Repeat
  • 1166755 2024-006
    Material Weakness Repeat
  • 1166756 2024-007
    Material Weakness Repeat
  • 1166757 2024-008
    Material Weakness Repeat
  • 1166758 2024-009
    Material Weakness Repeat
  • 1166759 2024-010
    Material Weakness Repeat
  • 1166760 2024-011
    Material Weakness Repeat
  • 1166761 2024-012
    Material Weakness Repeat
  • 1166762 2024-013
    Material Weakness Repeat
  • 1166763 2024-003
    Material Weakness Repeat
  • 1166764 2024-004
    Material Weakness Repeat
  • 1166765 2024-005
    Material Weakness Repeat
  • 1166766 2024-006
    Material Weakness Repeat
  • 1166767 2024-007
    Material Weakness Repeat
  • 1166768 2024-008
    Material Weakness Repeat
  • 1166769 2024-009
    Material Weakness Repeat
  • 1166770 2024-010
    Material Weakness Repeat
  • 1166771 2024-011
    Material Weakness Repeat
  • 1166772 2024-012
    Material Weakness Repeat
  • 1166773 2024-013
    Material Weakness Repeat
  • 1166774 2024-003
    Material Weakness Repeat
  • 1166775 2024-004
    Material Weakness Repeat
  • 1166776 2024-005
    Material Weakness Repeat
  • 1166777 2024-006
    Material Weakness Repeat
  • 1166778 2024-007
    Material Weakness Repeat
  • 1166779 2024-008
    Material Weakness Repeat
  • 1166780 2024-009
    Material Weakness Repeat
  • 1166781 2024-010
    Material Weakness Repeat
  • 1166782 2024-011
    Material Weakness Repeat
  • 1166783 2024-012
    Material Weakness Repeat
  • 1166784 2024-013
    Material Weakness Repeat
  • 1166785 2024-003
    Material Weakness Repeat
  • 1166786 2024-004
    Material Weakness Repeat
  • 1166787 2024-005
    Material Weakness Repeat
  • 1166788 2024-006
    Material Weakness Repeat
  • 1166789 2024-007
    Material Weakness Repeat
  • 1166790 2024-008
    Material Weakness Repeat
  • 1166791 2024-009
    Material Weakness Repeat
  • 1166792 2024-010
    Material Weakness Repeat
  • 1166794 2024-012
    Material Weakness Repeat
  • 1166795 2024-013
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.676 UNACCOMPANIED CHILDREN PROGRAM $5.28M
93.959 BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE $260,463